Hansard·Grand Committee·Vol. 861

Alzheimer’s Disease and Vascular Dementia

Thursday, 19 November 2026

12 contributions6 members

Contributions

  1. Question for Short Debate

    View contribution permalink →

  2. Asked by

    View contribution permalink →

  3. Lord Jackson of Peterborough

    To ask His Majesty’s Government what plans they have to enhance the provision of local community support for patients diagnosed with Alzheimer’s disease and vascular dementia.

    View contribution permalink →

  4. Lord Jackson of Peterborough (Con)

    My Lords, I am delighted to have the opportunity to raise this issue, which touches so many of our lives, including my own family’s. I know it is essentially a cross-party policy matter, and I am certain that the Minister, who I served with in the other place, is committed to the cause and will listen with great care and respond accordingly. I am indebted to Alzheimer’s Research UK and the Alzheimer’s Society for their work and for their help and support for me. The purpose of this debate is to address the present inadequacy in respect of the provision of local community support for patients diagnosed with Alzheimer’s disease and vascular dementia. The NHS has highlighted research showing that there are more than 944,000 people in the UK living with dementia—one in 11 people over the age of 65. It has been estimated that by 2030 the number of people with dementia in the UK will exceed 1 million, and the Alzheimer’s Society projects that by 2040 that figure may well exceed 1.4 million people. Dementia is the leading cause of death in the UK. The need for adequate local community support is acute and growing dramatically. Currently, the NHS recommends that individuals diagnosed with dementia should be given a care plan to be reviewed at least once a year, as both individuals and carers for those with dementia often require care and support. This is provided through the NHS, local authority adult social care services and a combination of national and local charities, as well as family and friends. However, the quality and availability of community support for patients diagnosed with Alzheimer’s disease and vascular dementia is demonstrably insufficient. Research by King’s College London identified issues concerning the accessibility of community support, including limited guidance, not being taken seriously and reports that emergency departments, rather than clinical expertise in the community, frequently become the path of least resistance to accessing care. This is corroborated by the Alzheimer’s Society’s 2025 report, Left in the Dark , which stated that one in five people affected by dementia have received no healthcare and no social care or financial support. Of those who received support, fewer than half were satisfied with it, with only 29% saying dementia-related healthcare was easy to access. A 2025 Care England and Dementia Forward report identified specific challenges for those seeking to access community support with young-onset dementia. It found that 95% of local authorities do not record young-onset dementia as a distinct category, while just 10% of local authorities report having any specialist young-onset dementia support locally. Other issues flagged by the Care Quality Commission’s 2025 report included lengthy waiting times for diagnosis and community support delivery, a lack of staff knowledge from care providers, poor communications and inequalities of care delivery. Regrettably, although some modelling suggests that 70% of care home residents are people living with dementia, there is no legal requirement for adult social care to undertake dementia training, and only 29% of staff in England in 2024 were recorded as having undertaken any dementia training. There are welcome signs, however, that the Government are seeking to engage with this issue. The ongoing Casey commission on adult social care has already outlined initial recommendations, which the Government have accepted in full, including using funding from the Dame Barbara Windsor dementia goals programme to trial new dementia drugs and appointing a new dementia tsar with national responsibility for the prevention, treatment and care of dementia. The Government have also recently committed to additional funding towards further dementia research. None the less, further action is required from the Government that would meaningfully impact the provision of community support for patients and carers affected. Since the 2024 general election, shadow Health Ministers have criticised this Government for the lack of priority given to improving dementia care and outcomes, including the removal of dementia diagnosis targets from NHS guidance to local health systems in 2025. One opportunity to make a difference through legislation was recently missed in the other place in Committee on the Health Bill, currently in our House in Committee. A cross-party amendment tabled by Joe Robertson MP was rejected and not added to the Bill; it would have required the Government to publish an annual report on the provision of dementia care. Alzheimer’s Research UK said that it welcomed the Government’s continuing development of a modern service framework for frailty and dementia, but it must be ambitious if it is to transform outcomes for people living with dementia. It recommends prioritising the following areas, which I hope that the Minister will address in her remarks. First, it suggested adopting innovation faster through a new national innovation implementation programme. My noble friend Lord Cameron’s recent public engagements as president of Alzheimer’s Research UK have focused on the ground-breaking research and innovation in Alzheimer’s drugs, which could have a transformative impact on the treatment of the disease in the near to medium-term future. I know that he is very optimistic about that and will no doubt elucidate that issue in his forthcoming Alzheimer’s podcast. Supporting this progress will facilitate the solutions that make the biggest difference to future generations’ engagement with Alzheimer’s and dementia. Secondly, delivering a consistent post-diagnostic national dementia pathway through standardised pathways for referral, assessment and treatment, with an immediate 18-week referral to diagnosis and care plan target, aims for the standardisation of best practice. Thirdly, we should measure what matters and hold the system to account through robust data mechanisms and reporting. This might, I hope, include a regular patient review with a named professional co-ordinating, guiding and proactively supporting in line with NICE guideline NG97. Additionally, there is a need for earlier access to transport, more equitable and consistent care across the country, increased access to research and innovation, and more proactive, personalised and joined-up care. I will finish with a few questions to the Minister, to which I know others will wish to contribute. How will the Government’s plans for developing Alzheimer’s and dementia community care consider the needs of those with young-onset dementia as a currently underrepresented group of individuals suffering with these diseases? What plans are there to support unpaid carers and to ensure that they have the support they need for training, respite care, home equipment and adaptions, benefits, legal planning, information and access to expertise, as well as very basic issues such as domiciliary care for the patient? Beyond funding, what regulatory pathways are the Government creating to accommodate groundbreaking Alzheimer’s and dementia drug and treatment research and development? Finally, what support is planned for peer and community initiatives such as dementia cafés, activity groups and services such as Singing for the Brain? This Government have an historic opportunity to tackle this difficult and multigenerational health emergency. If they do, they will have widespread support and good will. I thank the Minister in advance for her forbearance and very much look forward to the contributions from other noble Lords.

    View contribution permalink →

  5. Baroness Bottomley of Nettlestone (Con)

    My Lords, I wholeheartedly congratulate my noble friend on such a thoughtful and important contribution and on securing the debate in the first place. In the Government’s 10-year health plan, published last year, a member of the public described the difficulties of caring for a mother with dementia. Despite being directed towards numerous services, there was, in her words, no one taking responsibility for a solution. It is deeply troubling. A diagnosis should mark the beginning of a pathway to a dependable relationship with services, not the point at which families are left to navigate an increasingly complicated and confusing system on their own. I congratulate Alzheimer’s Research UK, which reminds us that nearly 1 million people in the UK are living with dementia. One in three do not have a formal diagnosis. One only has to reflect on the anxiety and stress this causes to the individual and the families concerned. People can come to terms with almost anything; the real killer is uncertainty. The geographical differences are striking. In Richmond, south-west London, the average waiting time for a diagnosis is 69 days. In Richmond, North Yorkshire—we must tell Rishi Sunak—it is 248 days. What can justify such a disparity? NICE guidance is admirably clear: every person living with dementia should have a named professional responsible for co-ordinating their care. The latest NHS England figures published in October show that only 63% of patients with a dementia diagnosis had a care plan or review recorded in the preceding 12 months. Can the Minister explain what practical steps the Government are taking to ensure that every patient has a named professional responsible for co-ordinating their continuing care? I also commend the remarkable and dedicated contribution from my noble friend Lord Cameron of Chipping Norton. As Prime Minister, he launched the Dementia Challenge in 2012, helping to transform the national conversation about a condition too often regarded as an inevitable consequence of aging. He doubled the investment in dementia research and brought international leaders together at the G8 Dementia Summit in 2013. His efforts have not diminished since leaving office. As my noble friend said, he is beginning a podcast and has been talking movingly about his mother, whom I remember fondly. He has spoken about the possibility of a statin for the brain, a treatment that might one day prevent or delay Alzheimer’s disease, just as statins have transformed cardiovascular prevention. There are many hopeful signs grounded in genuine advances in science. The first medicines shown to slow Alzheimer’s progression have been licensed in the UK, but they are not routinely available through the NHS. As a former Health Secretary, I fully recognise the importance of rigorous assessment of safety and cost-effectiveness, but I also recognise the signs of taking time and delaying before the Government have to take on the cost of some of these new advances that are wonderful but have serious resource implications. Alzheimer’s Research UK has articulated a compelling vision: a world free from the fear, harm and heartbreak of dementia. In its 10-year strategy, Towards a Cure , it envisages earlier and more accurate diagnosis, access to effective treatments and, ultimately preventing more people from developing these diseases. The charity’s recent Ready for a Cure report makes an equally important argument: scientific breakthroughs cannot improve patients’ lives unless the NHS has the capacity to adopt them, support clinical trials and provide appropriate care. Vascular dementia deserves particular consideration. Managing blood pressure, diabetes and other cardiovascular risks can help reduce further damage, while rehabilitation and OT can preserve independence. But such care depends on continuity between primary care, specialist services and support at home. I am sure that noble Lords are aware of research from King’s College London finding that inadequate community provision could make hospital emergency departments the path of least resistance to accessing care. We all know that, once a patient has been admitted through an emergency department, it is much more difficult to return them home. Let me mention unpaid carers. For many years, I worked with the late Baroness Seear. I was vice-chairman of what became Carers UK. The bravest thing we ever did was appoint a new chief executive. This was an unknown woman from Reading by the name of Jill Pitkeathley. Of course, she has gone from strength to strength but, at the time, it was quite a risky appointment; we spent a great deal of time deciding whether it was the right one to make. There is nothing more exciting than making an appointment that transforms the situation. But carers were simply not known about. I remember going on a programme to talk about it and they said, “This is Mrs Bottomley from the careers service”. This was not a term that was widely used. Another example of great courage and perseverance is Alastair Stewart, the broadcaster, and his courageous wife Sally, who are dear friends of mine. They have been involved in the Daily Mail ’s Dementia Carers Together appeal, in partnership with the Alzheimer’s Society and Alzheimer’s Scotland. Talking in public about these conditions is always painful and intrusive, but so often it is the human story that makes people think. Rather wonderfully, Alastair said, “What happens to the people who don’t have a Sal?”—a good point indeed. I also express my admiration for the Alzheimer’s Society, Dementia UK, Age UK and the many local charities whose dedication, specialist knowledge and personal relationships make such a difference. There are now genuine reasons for optimism. We are entering a new era in dementia research. For the first time, we have treatments that have been licensed and have been shown to halt or slow the progression of the disease. Blood-based biomarkers offer the potential to transform diagnosis, and make it faster and more accessible. Advances in research, diagnostics and healthcare data are opening up possibilities that would have been absolutely unimaginable a few years past. What we need is action, coherence and a timetable. I commend my noble friend Lord Jackson once more and look forward to the Minister’s comments.

    View contribution permalink →

  6. Lord Gascoigne (Con)

    My Lords, it is a pleasure to follow my noble friend and her thoughtful speech. Like her, I pay tribute to my noble friend Lord Jackson for securing this debate. He and I have spoken a number of times on this issue and I sincerely offer my respects to him and his family. Many come to this issue, indeed this debate, bearing the weight of their own experiences as well as concerns. Some will have direct experience of a family member, some will be caring for a loved one, and some will have a friend or a neighbour who is trying to look after someone. It is, alas, common, as we have heard. There is another statistic that stuck out for me: the Office of Health Economics said a couple of years ago that the lifetime likelihood of either developing dementia, becoming an informal carer for someone with dementia or both is 55%. In other words, around one in two people will be directly affected by dementia during their lifetime. For background, my mum was diagnosed with Alzheimer’s post Covid. She was always active throughout her life. After the main wave of Covid subsided, initially, my sister and I noticed a slight decline. Eventually, we managed to ensure that she was tested. One thing led to another; the decline became more noticeable and it was diagnosed as early Alzheimer’s. In many ways, she is lucky, and we are lucky. She is in a loving family. My mum’s husband will do all he can for her, and my sister and her family near to her will bash down doors to get any answers and support she needs. But even with that, it is tough. From the Library briefing, as well as from other experiences I have come across, I was struck not just by the complexity of each case but by how each case is individual and unique. As my noble friend touched on, we should not overlook those diagnosed at a relatively young age, particularly those who may live alone. They can face enormous practical and emotional challenges, and often require additional support if they are to continue living independently and safely. Equally, older couples, where one partner has dementia and the other takes on an informal caring role, can benefit greatly from regular support. This could come from home visits, but modern technology, as we have talked about, offers opportunities through, for example, online support groups, video consultations and regular virtual check-ins. All that can help reduce isolation and provide advice. Sadly, some families feel that the support available after diagnosis is not always sufficient to help them navigate the condition. That is not to say that it is all negative, and we should pay tribute to all who play their part. Indeed, the work of charities and voluntary organisations is invaluable—exceptionally so—but surely we cannot expect them to shoulder this growing burden alone. I kindly ask the Minister three questions. What further work can be done to highlight the early stages of this disease and show loved ones how to broach the subject in conversation, for example? It is not easy at the best of times for anyone—especially older people, who are rightly proud—but early diagnosis is hugely important. When will the Government set out the framework and how will they, alongside charities, drive a more consistent provision and use technology to support patients and families alike? Finally, out of interest, what work is being done to find a cure or better drugs, perhaps using AI? As we approach Christmas, I hope that we can come together in our determination to provide greater support, hope and clarity for those families affected. Many will gather with loved ones over the Christmas break. For some, it will be their first Christmas following a diagnosis. For others, it will be another year of a battle that they have been fighting for too long. Some will face it supported by families and friends; others will face it alone. From experience, I must confess that I find that there is a particular haunting sadness that accompanies this illness. It is found in the kiss of welcome as one notices a change in a loved one since they were last together. It is found in the silence of the room, once filled with laughter and conversation, yet where only the occasional glimmer of the person we know so well reappears. It is found in the kiss of farewell, wondering what the next visit will bring and whether there will be another at all. I have listened to the Minister speak on many occasions, including on this subject, both in public and private. I have always found her thoughtful, compassionate and deeply committed. I know that she cares about this issue and understands the profound impact that it has on patients, families and carers alike. It is in that spirit that I ultimately ask what further steps the Government will take to ensure that no person, and no family caring for them, feels abandoned after diagnosis and left to face the future alone. I genuinely wish her all the power on earth.

    View contribution permalink →

  7. Baroness Barker (LD)

    My Lords, the noble Lord, Lord Jackson of Peterborough, and I come from very different schools of political thought, and we are usually on opposite sides of an argument, but not today. I hope that we can find common cause, not least because it is a privilege to follow the noble Lord, Lord Gascoigne. As some noble Lords know, I spent the last five years being a carer for somebody who had a very rare neurological condition. I have to say that one of the things that enabled me to cope was the fact that she did not develop dementia. Some people do. When you have to care for somebody who has a physical condition along with dementia, that is the hardest thing of all. That is what we forget sometimes when we do the analysis of what the NHS provides for people with dementia: we put that into a separate compartment from other conditions. Increasingly, when we are talking about people who are living well into old age—and even younger people—we are actually talking about people carrying a double burden. It was the case in times gone by that there was no treatment at all following a diagnosis. Today, we have some glimmers of hope. People have talked about various drugs, Lecanemab being one, and this latest development, AR1001, being another; they are not yet available on the NHS but they hold out some hope of either delaying the development of symptoms or affecting an underlying treatment. The noble Lord, Lord Gascoigne, is right. With the development of AI, neuroscientists are increasingly working on programmes that identify biomarkers in large populations of people, which are leading them to at least identify people who are likely to develop the disease as a first stage, if not then going to a cure. The pace at which all that research is happening means that within the foreseeable future, we will have effective drug interventions. One question that I want to ask the Minister is: what work is being done now to gauge the level of demand on the NHS? How are we going to deal with issues such as access to medication? Are we going to be in a position whereby drug treatments will be licensed but not provided on the NHS, and families may then wish to buy drugs that are known to be effective but are not affordable on the NHS? Those are key ethical issues that the NHS has to deal with. We owe it, not least to those people and their carers, because they are a group of people who have consistently been denied continuing healthcare. We have always said, “There is no treatment, therefore these people do not require nursing, therefore they are not eligible for continuing healthcare”. Yet, with their care needs, if they are left alone without support, they very quickly develop health needs simply by dint of being unable to manage their own personal health and well-being. I also want to ask the Minister about the Prime Minister’s statement. There is a lot of hope in the air. The Prime Minister’s Statement has given a lot of hope that we will finally have effective political focus on this somewhat overlooked area of medicine. The UK Dementia Research Institute is a very important part of that. Its scientists have for some time been looking not just at drug interventions but at the whole way in which technology can enable people to live well and safely, using monitoring and adaptions around their house. The announcement of the £48 million is very welcome. However, can the Minister say exactly what that is going to go to? Many of the speeches that noble Lords have made have pointed to one thing. Even if you are somebody like me, who knows the NHS very well, finding your way around it and dealing with the different elements of care, some of which are great but are just disparate and unconnected, means that if there is a care pathway, the carer is in charge of it, not anybody else. Other people are making good interventions, but they are not putting it all together. I do not think we have yet fully understood the role that carers play in care management, could play in care planning and should play in directing some of the research. They are the people who watch patients day to day and are in a position to input some of the things that used to be called observation. The worst thing in a carer’s life is to have a health professional say that the person they care for has to go to A&E. That never works out well at all. There is one important thing that we could do in this country: we could teach and equip every carer to do simple observations—temperature, blood pressure and oxygen levels. If we did that, we might well be able to stop a lot of unnecessary A&E admissions, admissions that scare the life out of a person who has dementia, and worry their carers just as much because they know they are in the wrong place. We are at a time of great potential and great hope. I would like the Minister to tell us, as much as she can, whether some of that money will go to the voluntary sector to help them to pull many of these good initiatives together for individual people.

    View contribution permalink →

  8. Lord Kamall (Con)

    My Lords, I thank my noble friend Lord Jackson of Peterborough for securing this vital debate on the provision of community support for people diagnosed with Alzheimer’s and vascular dementia. He and my noble friend Lord Gascoigne have spoken of their own family experience of living with dementia. As we know, many families know someone who has been affected by dementia or have friends who do. As we have heard, dementia is the leading cause of death in this country. Although it is not necessarily only older people who have it, we have an ageing population so we will find, as we live physically longer, that more people will be diagnosed with dementia. I thought the title of this debate was really important. Most people think that Alzheimer’s and dementia are the same thing and often do not distinguish between the two. It is important that we make people aware of the other types of dementia, such as vascular dementia and dementia with Lewy bodies, frontotemporal dementia and mixed dementia. It is also important to mention young-onset dementia, as my noble friend Lord Jackson did, since it is often assumed that only old people are diagnosed with dementia. As my noble friend said, it is one of the greatest health and social care challenges facing our country. We know that we have many challenges with an ageing population, but this is clearly one of them, as was mentioned by the noble Baroness, Lady Casey, in her interim report. Behind every diagnosis and statistic is an individual, a family and often an unpaid carer whose life is profoundly affected, so timely diagnosis and co-ordinated care are essential to improve the lives of all involved, yet patients and their families must often overcome a fragmented and complicated system, as referred to by the noble Baroness, Lady Barker. My noble friend Lady Bottomley highlighted some of the regional variations, between the two Richmonds, for example, which well illustrates that point. We know that around 70% of care home residents are living with dementia or severe memory problems, while dementia places substantial pressure on hospitals and primary care. However, the burden is not borne by public services alone. The noble Baroness, Lady Pitkeathley, regularly and rightly reminds us of the thousands of unpaid carers who make enormous personal and financial sacrifices for loved ones. I must add a story from when I was Health Minister and I had to give an Answer on unpaid carers. The noble Baroness, Lady Pitkeathley, came up to me afterwards and said, “I can see you weren’t comfortable with the Answer you were given”. I said, “That’s absolutely right. I wasn’t comfortable. What more can I do?”, and we vowed to work together while I was Health Minister. Sadly, as we know happens in politics, particularly in those years, I was rapidly moved on, not because of that commitment to work with the noble Baroness but just because of the politics at the time. I really wish we had done more in government. This is not to make a party-political point; I think we can put our hands up and say, “Maybe we should have done more in government”. I ask the Minister: what additional support can the Government provide, in partnership with local community organisations, to these carers—for example, through respite and community-based services? That support must be accessible before families reach crisis point; that is absolutely essential. I want to share one of the organisations that I work with: Music for Dementia. Next week I will be hosting a lunch bringing together the music industry, tech companies, clinicians and some of those living with dementia to sign a pledge to develop new solutions—tech solutions and music solutions—to spread the power of music for dementia. There is so much research being done. Anyone who knows the power of music knows that listening to a song will take you back to a moment in time with a loved one, a family member or someone who is long departed. It instantly takes you back. That power of music has the potential to unlock memories or bits of memories that people think they have lost. There is incredible research going on, and I recommend the work of many of the organisations that are looking at the power of this for dementia—not only Music for Dementia but the other organisations and academics who are looking at this. I also welcome the Government’s commitment to introduce a modern service framework for frailty and dementia. I appreciate that it aims to reduce unwarranted variation by establishing national standards of care, but we must ensure that this framework delivers tangible improvements rather than remains a list of aspirations, as so often happens with successive Governments. Can the Minister confirm whether the framework will be fully published by the end of 2026? If not, is she able to give a more precise timetable than “in due course” or “at pace”? Significantly, will it include measurable targets, not only ultimate targets but interim targets for community support? How will the Government hold local health systems accountable for delivering them? We all agree with the mantra about moving from hospital to community, but where is the accountability when that is not delivered? I remain concerned about the removal of the early dementia diagnosis rate target from NHS operational planning guidance for 2025-26. It seems an unnecessary and careless measure that contradicts the scale of the growing crisis. Some 67% of people with dementia should have a diagnosis, and the NHS should strive to meet that target. Is the Minister able to explain why this target has been removed or have I misunderstood that? Maybe the Minister could clarify, especially as dementia prevalence and awareness of dementia continue to rise. As other noble Lords have said, my honourable friend Joe Robertson proposed in the other place to have annual reporting on dementia care outcomes, enabling Parliament to assess and scrutinise progress against national standards. Given that that proposal, regrettably, was not adopted, will the Minister consider annual reporting? What other sort of reporting would they consider to strengthen transparency and accountability? I hope that the Minister will consider reinstating some sort of target and annual reporting, or encourage relevant colleagues in the department, because these measures would serve only to strengthen care. I turn to address the quality and availability of specialist care. With only a minority of adult social care staff recorded as having received dementia-specific training, there are clearly concerns about consistency of care. Can the Minister tell us whether there are plans to expand access to specialist dementia training, which would provide invaluable support to patients and their families? Maybe we could work with organisations that are specialists in this. It does not always have to be the Government, as we could work with civil society organisations. We also welcome the Prime Minister’s announcement, as many other noble Lords have, building on the Prime Minister’s personal experience. That is really important. Of course, the previous Government had the Dame Barbara Windsor dementia mission, launched in 2022, showing that this is not a party-political issue. I have run out of time. There are lots more questions, so the Minister has been saved by the bell. I will turn these into Written Questions, much to the consternation and concern of the officials in the Box. I end by saying that this is not a party-political issue. I think we all agree that we want the same outcomes. We may disagree on how we achieve them, but we all look forward to the Minister’s response.

    View contribution permalink →

  9. The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)

    My Lords, I congratulate the noble Lord, Lord Jackson of Peterborough, on securing this debate, which rightly highlights how much of the support offered—or indeed not offered, to the points made by noble Lords—is or is not provided in the community. I am grateful to the noble Lord for his introduction and to all noble Lords for the tone of the debate and the acknowledgement of the progress that we are making. The challenge we have has not grown up overnight but is one that falls to us to deal with. It affects so many of us, directly or indirectly, including our own families and friends. The noble Lord, Lord Gascoigne, spoke of a haunting sadness, which I felt encapsulated not just the feeling but the reality—and I thank him for it. That reminded me of two things. First, not everybody has family and friends to call on who can provide support, and we should never expect it—a point made regularly in our Chamber, and rightly so. Secondly, this matter affects and is moving our own Prime Minister, as it has affected and moved previous Prime Ministers, including the noble Lord, Lord Cameron. There is probably hardly a Peer who is untouched in some way by this. So I am very grateful to noble Lords. Alzheimer’s disease and vascular dementia are two of the most common forms of dementia and those living with them have unique and, usually, long-term needs. I will be using the umbrella term “dementia”. Every person with dementia deserves high-quality, compassionate care and support from diagnosis right through to the end of life. That includes enabling them to live well and independently in their own homes and communities for as long as possible, if they wish to do so. Service provision is the responsibility of local integrated care boards, so that they can provide properly for their local communities. Noble Lords who have been involved in the Health Bill will know that we are strengthening that position, including on accountability. ICBs work within NHS England’s well pathway for dementia, which highlights that services need to be integrated, commissioned, monitored and aligned with NICE standards, as referred to in this debate. That pathway makes it clear that the needs, wishes and preferences of each individual should be taken into account when planning and providing their care, including what type of dementia they are living with and their particular challenges. We have published the D100 assessment tool pathway programme to bring resources together into a single tool to simplify best practice and provide the best care and support. As we have heard, we face many challenges in dementia care. We are taking steps to meet them, though I am sure that more can be done. I will raise some of the points raised by noble Lords with the Minister for Care, Alison McGovern MP, for her consideration, such as support for families in identifying what is going on, as the noble Lord spoke about. In response to the noble Lords, Lord Gascoigne and Lord Kamall, I can confirm that by the end of this year we will publish the first ever modern service framework for frailty in dementia. That is really important. It will give us a long-term blueprint to deal with this. Its aim will be to reduce variation and inequalities for those who live with dementia. It will set national standards for care and redirect NHS priorities. The noble Lord, Lord Jackson, spoke about the Alzheimer’s Society report Left in the Dark , which highlighted the lack of support. I am more than hopeful, and the whole intention is for that framework to take on board that challenge. Noble Lords referred to the work of the noble Baroness, Lady Casey, which I also welcome. We are taking forward her initial recommendations, which include appointing a national dementia tsar to ensure the authoritative leadership that we need across prevention all the way through to care, research and treatment. That appointee will convene partners through a new dementia council, which will drive the delivery of the modern service framework and challenge on progress. I absolutely agree with the noble Baronesses, Lady Bottomley and Lady Barker, and other noble Lords who described just how difficult this is. It should not a test of whether you can get past the fragmented silos. I absolutely accept the way that the current situation has been described—but that is all I accept; I do not accept that unwanted geographic variations are acceptable, and I do not accept the inconsistency, delay and variability that noble Lords have described. Nor do I accept the fragmentation across primary care on care pathways, which is what we seek to change through our actions. I am pleased to say that yesterday—the noble Lord, Lord Jackson, is very timely in getting this debate; I do not know how he did it—the Secretary of State set out how we will rebuild support around those with the greatest health and care needs, expressly including people living with dementia, through new neighbourhood support teams that co-ordinate their care, head off crises and—the noble Baroness, Lady Barker, spoke to this point—help them stay well at home rather than ending up in hospital, and particularly in A&E. This is the proactivity that my right honourable friend spoke about. Each person enrolled will have a named lead person responsible for co-ordinating their care, a shared care plan built around what matters to them and a team that knows them. As such, they and their loved ones will not have to do what noble Lords have spoken about: navigating fragmented services by themselves. By 2027, 95% of those with complex needs will have an agreed care plan. This winter, we are also investing £40 million, so that GPs can identify those most at risk and make sure those care plans are up to date.

    View contribution permalink →

  10. Lord Jackson of Peterborough (Con)

    Anecdotally, one of the issues that comes up—I am not criticising GPs; there is some superb primary care provision for patients with dementia—is that, once medication is put in place, it is not often reviewed. Medication has a big impact on different patients over different lengths of time. Is that an area of consideration? I know it is a very granular issue, but if people’s medication is not reviewed in a timely way, it can impact their capacity to stabilise the condition.

    View contribution permalink →

  11. Baroness Merron (Lab)

    The noble Lord is quite right. I do not think it is granular; it is key to any care plan. I would expect that to go on even now as part of the prescribing process. People living with dementia will be among the first to benefit from that investment into GPs, to ensure that the care plans are up to date—to the point that the noble Lord has just raised. From next year, every ICB will be required to commission a care management service, starting with those at the highest risk and expanding over time. I turn to research and treatments—on the points and areas of detail that I have not been able to cover, I will be very pleased to write to noble Lords. We are investing in dementia research across all areas, from cause, diagnosis and prevention to treatment, care and support, including for carers. I am glad that the noble Baroness, Lady Bottomley, and the noble Lord, Lord Jackson, discussed unpaid carers—they are so key. We are assisting them, for example, through a new MyCarer section on the NHS app. It was only today that Anna Dixon MP was appointed as the champion for unpaid carers, which will also bring focus to them. I also agree with the credit paid to my noble friend Lady Pitkeathley for her efforts, which are always to be commended. The Dame Barbara Windsor Dementia Goals programme aims to realise a new generation of precision dementia therapies and solutions by accelerating innovations. We are investing £33 million in this programme to support the work of the BARBARA Alliance and its flagship project, BARBARA. That will create a single platform that will bring together the UK’s health data, research and clinical trial capabilities. This is an exciting time for dementia research. As noble Lords have said, new innovations can transform the diagnosis and treatment of dementia. I finish on this point: NICE is currently evaluating drugs for early Alzheimer’s disease. We certainly encourage any companies developing new treatments to engage with NICE and NHS England, because—to the point that the noble Baroness, Lady Barker, made—we want to support patient access to clinically and financially effective treatments. This is a topic close to many people’s hearts. It is a very personal matter for many, and I can commit, on behalf of the Government, that we will continue to work on it. I am grateful for the support, interest and challenge from noble Lords today.

    View contribution permalink →

  12. Committee adjourned at 4.06 pm.

    View contribution permalink →

Source: UK Parliament Hansard API. Debate ID: 5441480.